Another paclitaxel-coated balloon has demonstrated better efficacy and less need for reinterventions at 1-year compared with a standard uncoated balloon for the treatment of superficial femoral artery ...

Drug-coated balloons (DCB) have recently garnered significant attention and acceptance in the realm of interventional cardiology. These innovative devices are increasingly utilized, predominantly ...

In a showdown of drug-coated balloons (DCBs) for peripheral artery disease, the investigational Chocolate Touch device came out superior on efficacy in an open-label randomized trial. Among over 300 ...

Adding a balloon or stent procedure (endovascular angioplasty to widen blood vessels in the neck) to standard treatment may make little to no difference to the chance of another stroke or mini-stroke ...

Six Month Data of the LEVANT 2 Trial Presented at TCT 2013 SAN FRANCISCO, CA – The first clinical trial in the United States to study the use of drug coated balloons (DCB) for femoropopliteal artery ...

The FDA gave PMA approval to Medtronic's ($MDT) IN.PACT Admiral drug-coated balloon for the treatment of peripheral artery disease in the upper leg, making it a ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — In patients with long femoropopliteal artery disease, treatment with a paclitaxel-coated balloon ...

Balloon angioplasty is a minimally invasive procedure to treat blocked or narrowed arteries. It involves inserting a tiny balloon into a blood vessel and inflating it to treat blockages and improve ...

The Mount Sinai Hospital is first in the United States to use the first and only FDA-approved, drug-coated balloon to open blocked arteries in the leg. The device is used during an angioplasty ...

Peripheral artery disease (PAD), sometimes also called peripheral vascular disease (PVD), is a circulation disorder that slowly gets worse over time. Calcium and fat materials build up inside the ...

Patients treated for a blocked artery in the leg were significantly more likely to have an open artery without further interventions at 12 months if they received the second-generation ...